本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

0.8191
+0.00670.82%
盘后0.7900-0.0291-3.55%19:59 EDT
成交量:2.52万
成交额:2.07万
市值:2,671.47万
市盈率:-1.51
高:0.8340
开:0.8201
低:0.8001
收:0.8124
52周最高:3.85
52周最低:0.5714
股本:3,261.47万
流通股本:562.08万
量比:0.03
换手率:0.45%
股息:- -
股息率:- -
每股收益(TTM):-0.5428
每股收益(LYR):-1.6570
净资产收益率:-112.02%
总资产收益率:-28.56%
市净率:1.04
市盈率(LYR):-0.49

数据加载中...

2019/08/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

招股说明书

Registration statement for certain foreign private issuers
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers